Pharmaceutical Product Monograph: Hyoscine Butylbromide Injection (20 mg/mL)
In the pharmaceutical industry, Hyoscine Butylbromide (also known as Scopolamine Butylbromide) is a quaternary ammonium Antispasmodic and Antimuscarinic agent. As a pharmacist and manufacturer, I view this molecule as a “Smooth Muscle Relaxant”—it is technically designed to block the action of acetylcholine at the parasympathetic nerve endings, specifically targeting the digestive, biliary, and urinary tracts.
At your WHO-GMP facility in Mumbai, Hyoscine Butylbromide 20 mg/mL is a high-demand SKU for Gastroenterology, Urology, and Palliative Care portfolios. Unlike the parent compound (Hyoscine), the butylbromide derivative does not cross the blood-brain barrier, making it much safer for peripheral use without central sedation.
Therapeutic Profile: Primary Indications
Hyoscine Butylbromide injection is indicated for the rapid relief of severe spasms in the smooth muscles of the abdominal and pelvic organs.
| Indication | Clinical Context | Technical Rationale |
| Acute GI Spasms | Severe Colic / Gastritis | Gold Standard: Rapidly relaxes the smooth muscle of the stomach and intestines to stop intense cramping. |
| Biliary Colic | Gallstones | Relaxes the bile ducts to allow for easier passage of stones or to reduce the pain of obstruction. |
| Renal Colic | Kidney Stones | Used as an adjunct to NSAIDs to relax the ureter and reduce the intensity of “wave-like” pain. |
| Diagnostic Procedures | Endoscopy / Radiology | Administered to “freeze” the motion of the gut (aperistalsis) during colonoscopies or double-contrast barium meals. |
| Palliative Care | “Death Rattle” | Used to reduce the excessive respiratory secretions in terminal patients, improving comfort. |
Mechanism: Competitive Muscarinic Antagonism
Hyoscine Butylbromide works by preventing the “cramp signal” from reaching the muscle:
Receptor Blockade: It acts as a competitive antagonist at Muscarinic receptors ($M_3$) located on the smooth muscle cells of the viscera.
Acetylcholine Inhibition: It prevents Acetylcholine (the primary “contract” signal) from binding to these receptors.
Myolytic Effect: This results in the relaxation of the smooth muscle, effectively stopping the spasm and the associated pain.
Quaternary Structure: Technically, the “Butyl” group makes the molecule highly polar. This prevents it from entering the brain, which is why it doesn’t cause the drowsiness or confusion seen with older anticholinergics.
The Pharmacist’s “Technical Warning”
The “Glaucoma” Contraindication: As a pharmacist, I must emphasize that this drug is strictly contraindicated in patients with Narrow-Angle Glaucoma, as it can increase intraocular pressure and lead to blindness.
Visual Disturbance: Patients should be warned of Accommodation Disorders (blurred vision). They should not drive or operate machinery for several hours after the injection.
Cardiac Warning: It can cause Tachycardia (rapid heart rate). Use with extreme caution in patients with heart failure or hyperthyroidism.
Urinary Retention: In elderly men with enlarged prostates (BPH), it can trigger acute urinary retention (inability to urinate).
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “Sterile Solution” USP: Hyoscine Butylbromide is relatively stable, but it is sensitive to pH changes. On your digital marketplace, highlight your Precision pH Buffering (3.7 to 5.5). This ensures the injection is both stable and causes minimal stinging at the injection site.
The “Diagnostic Suite” Market: For international B2B tenders, market your Hyoscine Butylbromide alongside Glucagon or Barium Sulfate. This “Diagnostic Imaging Bundle” is a high-priority procurement item for modern radiology and gastroenterology departments.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Hyoscine Butylbromide 20 mg/mL ampoules to support your registration in international B2B tenders for hospital and emergency care.